Atypical Angiogenic Mimicry During Collective Lung Cancer Invasion

肺癌集体侵袭过程中的非典型血管生成拟态

基本信息

  • 批准号:
    9973155
  • 负责人:
  • 金额:
    $ 35.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-08 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract Collective invasion is a major mode of metastasis observed in patients across most solid tumor types. How the collective invasion pack operates, communicates, and navigates as a single cohesive unit remains unclear. To address this, we published on an image-guided genomics platform to isolate any living cell(s) within a collective invasion pack, and expand the population for genomic and molecular analysis, a technique we termed Spatiotemporal Cellular & Genomic Analysis (SaGA). We used SaGA to deconstruct the collective invasion pack and dissect the molecular profiles of leader and follower cells invading as a hierarchical cohesive unit. To generate the collective invasion pack, leader and follower cells undergo a VEGF/Notch-based angiogenic mimicry program that promotes cell:cell cooperation and invasion that is similar, but not identical to angiogenesis. VEGF secreted by invasive leaders recruits proliferative followers into the collective pack; once the pack is formed, leader and follower cells undergo a Notch1-Dll4 cell patterning program that includes the Dll4 antagonist, Jagged-1 (Jag1). Based upon our published and preliminary data, we hypothesize that cooperative signaling among contiguous cells via Notch1 and its ligands are required to form the spatially dependent signaling events within the invasion pack. We propose that this fosters cell:cell cooperation and leads to increased metastatic efficiency. To test this, in Aim 1 we will define how atypical angiogenic mimicry via Notch1/Jag1/Dll4 signaling operates to spatially regulate cooperation and invasion. This would be a significant step forward in understanding how this pathway operates to maintain the collective invasion pack, drive metastasis, and facilitate ECM remodeling. In Aim 2, we use Jag1 as a lung cancer leader cell biomarker to isolate the first patient leader cells and probe atypical angiogenic mimicry. This allows us to define the metastatic potential and translational impact of this rare yet invasive population in lung cancer patients. Throughout, we leverage unique resources developed here including SaGA-derived cell lines, the first set of early and late-stage invading lung patient-derived organoids, ex vivo imaging, and a rare set of lung primary tumors with paired metastatic brain tissue. We speculate that these data will provide mechanistic insight into the atypical angiogenic mimicry program and translational value towards understanding lung cancer patient leader cell biology.
摘要 集体侵袭是在大多数实体瘤类型的患者中观察到的主要转移模式。如何 集体入侵包作为一个单一的内聚单位运作,通信和导航仍然不清楚。到 为了解决这个问题,我们发表了一个图像引导的基因组学平台,以分离集体中的任何活细胞。 入侵包装,并扩大人口的基因组和分子分析,一种技术,我们称之为 时空细胞和基因组分析(佐贺)。我们用佐贺来解构集体入侵包 并将入侵的领导细胞和跟随细胞作为一个层次性的凝聚单位进行分子剖析。到 产生集体入侵包,领导和追随者细胞经历基于VEGF/Notch的血管生成 模拟程序,促进细胞:细胞的合作和入侵,类似,但不完全相同的血管生成。 由入侵性领导者分泌的VEGF将增殖性追随者招募到集体包中;一旦包 形成的前导细胞和跟随细胞经历包括D11 4拮抗剂的Notch 1-D11 4细胞图案化程序, 锯齿状-1(Jag 1)。根据我们已发布的和初步的数据,我们假设合作信号传递 在相邻细胞之间通过Notch 1及其配体是形成空间依赖性信号事件所必需的 在入侵包中。我们认为,这促进了细胞:细胞合作,并导致增加转移 效率为了验证这一点,在目标1中,我们将定义非典型血管生成拟态如何通过Notch 1/Jag 1/Dll 4信号传导 在空间上调节合作和入侵。这将是我们了解 这一通路如何运作以维持集体侵袭包,驱动转移,并促进ECM 重塑在目标2中,我们使用Jag 1作为肺癌前导细胞生物标志物来分离第一个患者前导细胞。 探索非典型血管生成拟态这使我们能够确定转移潜力和翻译影响, 这种罕见但具有侵袭性的人群的肺癌患者。在整个过程中,我们利用开发的独特资源 这里包括SaGA衍生的细胞系,第一组早期和晚期侵袭性肺患者衍生的细胞系, 类器官、离体成像和一组罕见的肺原发性肿瘤与成对的转移性脑组织。我们 推测这些数据将为非典型血管生成模仿程序提供机制见解, 对理解肺癌患者领导细胞生物学的转化价值。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adam I. Marcus其他文献

TGF-β1-mediated intercellular signaling fuels cooperative cellular invasion
转化生长因子-β1(TGF-β1)介导的细胞间信号传导促进了细胞的协同侵袭。
  • DOI:
    10.1016/j.celrep.2025.115315
  • 发表时间:
    2025-02-25
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Tala O. Khatib;Brian A. Pedro;Sergei Bombin;Veronika Y. Matsuk;Isaac E. Robinson;Sarah F. Webster;Landon J. Marcus;Emily R. Summerbell;Gregory K. Tharp;Christina M. Knippler;Pritha Bagchi;Jeanne Kowalski-Muegge;H. Rich Johnston;Homa Ghalei;Paula M. Vertino;Janna K. Mouw;Adam I. Marcus
  • 通讯作者:
    Adam I. Marcus
High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinoma
  • DOI:
    10.1007/s00432-025-06269-9
  • 发表时间:
    2025-07-26
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Rebecca E. Parker;Leon McSwain;Wei Zhou;Adam I. Marcus;Haian Fu;Suresh S. Ramalingam;Shirley Zhang;Melissa Gilbert-Ross
  • 通讯作者:
    Melissa Gilbert-Ross
A two dimensional simulation of microtubule dynamics
微管动力学的二维模拟
The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein export
RAS•GTP:RanGAP1 复合物的致癌非经典活性促进核蛋白输出
  • DOI:
    10.1038/s43018-024-00847-5
  • 发表时间:
    2024-11-11
  • 期刊:
  • 影响因子:
    28.500
  • 作者:
    Brajendra K. Tripathi;Nicole H. Hirsh;Xiaolan Qian;Marian E. Durkin;Dunrui Wang;Alex G. Papageorge;Ross Lake;Yvonne A. Evrard;Adam I. Marcus;Suresh S. Ramalingam;Mary Dasso;Karen H. Vousden;James H. Doroshow;Kylie J. Walters;Douglas R. Lowy
  • 通讯作者:
    Douglas R. Lowy

Adam I. Marcus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adam I. Marcus', 18)}}的其他基金

Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
项目3:抑制FAK增强免疫检查点抑制剂治疗LKB1突变型肺腺癌
  • 批准号:
    10411668
  • 财政年份:
    2022
  • 资助金额:
    $ 35.69万
  • 项目类别:
Cleared Tissue Large FOV Microscope Request
透明组织大视场显微镜请求
  • 批准号:
    10429884
  • 财政年份:
    2022
  • 资助金额:
    $ 35.69万
  • 项目类别:
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
项目3:抑制FAK增强免疫检查点抑制剂治疗LKB1突变型肺腺癌
  • 批准号:
    10631151
  • 财政年份:
    2022
  • 资助金额:
    $ 35.69万
  • 项目类别:
Implications of metabolic heterogeneity on collective lung cancer cell invasion
代谢异质性对肺癌细胞集体侵袭的影响
  • 批准号:
    10383657
  • 财政年份:
    2021
  • 资助金额:
    $ 35.69万
  • 项目类别:
Spatiotemporal interrogation of metabolic cooperation between heterogenous lung cancer subpopulations in collective cell invasion
集体细胞侵袭中异质肺癌亚群之间代谢合作的时空询问
  • 批准号:
    10818222
  • 财政年份:
    2021
  • 资助金额:
    $ 35.69万
  • 项目类别:
Implications of metabolic heterogeneity on collective lung cancer cell invasion
代谢异质性对肺癌细胞集体侵袭的影响
  • 批准号:
    10672179
  • 财政年份:
    2021
  • 资助金额:
    $ 35.69万
  • 项目类别:
Deconstructing the collective invasion pack to define Myo10 function
解构集体入侵包定义Myo10功能
  • 批准号:
    10611926
  • 财政年份:
    2020
  • 资助金额:
    $ 35.69万
  • 项目类别:
Deconstructing the collective invasion pack to define Myo10 function
解构集体入侵包定义Myo10功能
  • 批准号:
    10159870
  • 财政年份:
    2020
  • 资助金额:
    $ 35.69万
  • 项目类别:
Deconstructing the collective invasion pack to define Myo10 function
解构集体入侵包定义Myo10功能
  • 批准号:
    10400713
  • 财政年份:
    2020
  • 资助金额:
    $ 35.69万
  • 项目类别:
Atypical Angiogenic Mimicry During Collective Lung Cancer Invasion
肺癌集体侵袭过程中的非典型血管生成拟态
  • 批准号:
    10439630
  • 财政年份:
    2019
  • 资助金额:
    $ 35.69万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了